Free Trial

Stoke Therapeutics (STOK) SEC Filings & 10K Form

$14.41
-0.30 (-2.04%)
(As of 05/24/2024 ET)

Recent Stoke Therapeutics SEC Filings

DateFilerForm TypeView
05/22/2024
3:15 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:17 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:20 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:21 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:06 PM
Stoke Therapeutics (Filer)
Form DEF 14A
04/23/2024
3:08 PM
Stoke Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:11 PM
Stoke Therapeutics (Filer)
Form ARS
04/18/2024
3:16 PM
Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:18 PM
Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
Form SC 13D/A
04/17/2024
3:17 PM
Ezbon International Ltd (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2024
3:06 PM
Stoke Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/03/2024
3:19 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
3:36 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
4:20 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:47 PM
Stoke Therapeutics (Filer)
Form 424B5
03/25/2024
3:03 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:07 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:07 PM
Stoke Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2024
7:29 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:30 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:31 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:34 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:36 PM
Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
9:36 AM
Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G
02/26/2024
9:38 AM
Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
02/15/2024
3:17 PM
Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:20 AM
Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
02/14/2024
6:44 AM
RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
02/09/2024
1:51 PM
MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
02/05/2024
3:32 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:49 PM
Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:09 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
3:15 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:17 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:18 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:20 PM
Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
8:04 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
3:37 PM
Stoke Therapeutics (Subject)
Form SC TO-I/A
11/07/2023
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Truth about Trump you’ve never heard (Ad)

Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump.

For the full story, click here.
11/02/2023
8:01 AM
Stoke Therapeutics (Subject)
Form SC TO-I
10/26/2023
4:00 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
3:44 PM
SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2023
3:48 PM
SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:37 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:05 PM
Stoke Therapeutics (Filer)
Form PRE 14A
09/08/2023
3:15 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2023
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
4:20 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:45 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
3:18 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
5:24 PM
LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:25 PM
Menzel Garry E (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:26 PM
Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:26 PM
Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:22 PM
Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:23 PM
Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:24 PM
Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
6:31 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:15 PM
Stoke Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:STOK) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners